Acaya is a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting Bruton’s tyrosine kinase (BTK), which helps stop the growth of cancer cells.
| Manufacturer | Zydus |
| Generic Name | Acalabrutinib |
| Strength | 250mg |
| Pack size | 60 Capsules |
| Used For | Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma |
Acaone 100 mg Capsules contain Acalabrutinib, a targeted therapy used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. It works by blocking cancer cell growth and progression.
| Manufacturer | MSN |
| Generic Name | Acalabrutinib |
| Pack size | 30 Capsules |
| Used For | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma |
Acalnib 100 mg Capsules contain Acalabrutinib, a targeted therapy used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.
| Manufacturer | Hetero |
| Generic Name | Acalabrutinib |
| Pack size | 30 Capsules |
| Used For | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma |
Acabrunat 100 mg Capsule contains Acalabrutinib, a targeted therapy used to treat certain types of blood cancers such as mantle cell lymphoma and chronic lymphocytic leukemia (CLL).
| Manufacturer | Natco |
| Generic Name | Acalabrutinib |
| Pack size | 30 Capsules |
| Used For | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma |
